Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan)
Olsen JO, Pozderac RV, Hinkle G, et al. Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). Semin Nucl Med 1995;25:251-61.
Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy and impact on patient management
Jamar F, Fiasse R, Leners N, et al. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-9.
Receptor scintigraphy with indium-111-pentetreotide for endocrine gastroenteropancreatic tumors
Joseph K, Stapp J, Reinecke J, et al. Receptor scintigraphy with indium-111-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res Suppl 1993;27:28-35.
Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: A comparative study
King CMP, Reznek RH, Bomanji J, et al. Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: A comparative study. Clin Radiol 1993;48:386-91.
Somatostatin-receptor imaging of human malignancies: A new era in the localization, staging, and treatment of tumors
Kvols LK. Somatostatin-receptor imaging of human malignancies: A new era in the localization, staging, and treatment of tumors. Gastroenterology 1993;105:1909-14.